AI-Based Biopsy Sparing for BI-RADS 4A+ Breast Lesions May Guide Clinical Decisions

AI-based biopsy sparing for BI-RADS 4A+ breast lesions can be translated into clinically actionable decision-making, suggests a new study in J Ultrasound Med.

• The AI-based approach targets ultrasound BI-RADS 4A+ breast lesions to potentially avoid unnecessary biopsies.
• The research is published in the Journal of Ultrasound in Medicine, a peer-reviewed society journal.

RadPigeon summaries are original and for information only. They are not clinical advice.